Added to YB: 2026-03-12
Pitch date: 2026-03-10
BAYN.DE [neutral]
Bayer Aktiengesellschaft
+0.29%
current return
Author Info
Duck Pond Value Research is seeking tranquil ponds with a value philosophy. Margin of safety is not just a mantra. Follow us for investment theses, sector reports, or our economic perspectives. Sometimes ponds can be moats. Sign up for the newsletter.
Company Info
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
Market Cap
EUR 36.9B
Pitch Price
EUR 39.02
Price Target
N/A
Dividend
0.29%
EV/EBITDA
7.31
P/E
-10.20
EV/Sales
1.47
Sector
Pharmaceuticals
Category
turnaround
The Pond Tracker | Mar '26 - Bayer Aktiengesellschaft
BAYN.DE (update): Down 11% on conflict start & litigation guidance concerns, but investment case intact. Roundup settlement at $7.25B (vs $6.7-8.4B est) could unlock re-rating as solid pharma + ag giant. CEO Anderson bought 21k shares (~€8M total, 2x board requirement), incoming CFO Hartmann added €500k, signaling confidence in turnaround.
Read full article (1 min)